title: [Trastuzumab-induced cardiomyopathy].
abstract: The treatment of malignant tumors may cause severe adverse reactions including cardiovascular problems. The case of a young woman with trastuzumab (Herceptin) induced dilatation cardiomyopathy with favorable outcome is presented in the article.
authors.forename: L S
authors.initials: LS
authors.lastname: Avchukhova
authors.forename: L V
authors.initials: LV
authors.lastname: Salamatina
authors.forename: I A
authors.initials: IA
authors.lastname: Urvantseva
authors.forename: O V
authors.initials: OV
authors.lastname: Kudriavtseva
authors.forename: A V
authors.initials: AV
authors.lastname: Rudenko
authors.forename: D P
authors.initials: DP
authors.lastname: Morgunov
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D002311:Cardiomyopathy, Dilated / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D006801:Humans; D000068878:Trastuzumab
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab